Quadria Capital has closed its third healthcare-focused fund at $1.07 billion—well above its $800 million target. The goal: to support and scale healthcare companies across South and Southeast Asia, a region seeing rapid demand for quality healthcare.
The fund includes $954 million in core investments and $114 million in co-investments, with another $300 million expected during the fund’s lifecycle. This marks Quadria as the largest healthcare-dedicated private equity firm in the region.
This fund comes at a critical moment. Healthcare in Asia is under the spotlight, with global investors eyeing growth in the region. According to a Boston Consulting Group (BCG) report, Asia-Pacific’s healthcare market is set to reach $5 trillion by 2030, making up 40% of global growth, even though it currently only accounts for 22% of worldwide healthcare spending.
“Closing Fund III during such a tough fundraising period validates our mission,” said Abrar Mir, Co-founder and Managing Partner at Quadria. “There’s strong global confidence in Asia’s healthcare transformation.”
Quadria investment strategy
Quadria Capital has already deployed nearly 40% of the capital in leading healthcare companies like:
- Aragen Life Sciences – a global contract research and manufacturing firm (CRDMO)
- NephroPlus – Asia’s largest dialysis network
- Maxivision Eye Hospitals
More deals are expected soon in Southeast Asia, focusing on areas such as:
- Specialized hospitals
- Diagnostic services
- Pharmaceutical manufacturing (including APIs and CDMOs)
- Digital healthcare platforms
Digital health is growing fast in the region, with platforms like PharmEasy and MediBuddy seeing explosive growth since 2019.
“Asia is entering a golden decade of healthcare,” said Dr. Amit Varma, Quadria’s Co-founder. “We invest in bold healthcare leaders and help scale their impact with strategic and operational support.”
As Asia faces rising demand for elder care and chronic disease treatment, and tech reshapes how care is delivered, Quadria’s fund is positioned to fuel innovation and expand access to healthcare.
Founded in 2012, Quadria Capital now manages over $4 billion in assets and has backed 27 healthcare companies across India, Vietnam, Indonesia, Malaysia, and Singapore.
